CSPC Pharmaceutical Group Limited announced that reference is made to the announcement of the company dated November 1, 2018, where it was announced that the company entered into the 2018 master sales agreement with CHL on November 1, 2018, pursuant to which, among others, the company agreed to supply, and to procure its subsidiaries to supply, pharmaceutical products to the CHL Group. As the 2018 master sales agreement had expired on October 31, 2021, on November 22, 2021, the company entered into the 2021 master sales agreement with CHL, pursuant to which the company agrees to supply, and to procure its subsidiaries to supply, pharmaceutical products to the CHL Group for a period of three years commencing from November 1, 2021.